Asset
Aspirin
Boston Scientific Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01510327 | phase3 | completed | 2009-10-01 | 2010-02-01 | Boston Scientific Corporation | PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) |
| NCT01589978 | phase4 | completed | 2012-05-01 | 2014-08-01 | Boston Scientific Corporation | PROMUS Element Plus US Post-Approval Study |
| NCT00823212 | phase3 | completed | 2009-01-01 | 2010-09-01 | Boston Scientific Corporation | The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions |
| NCT01500434 | phase3 | completed | 2009-02-01 | 2011-03-01 | Boston Scientific Corporation | The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) |
FDA applications (0)
This company has no applications containing this asset.